Page last updated: 2024-11-02

pd 98059 and Neurovisceral Storage Disease with Vertical Supranuclear Ophthalmoplegia

pd 98059 has been researched along with Neurovisceral Storage Disease with Vertical Supranuclear Ophthalmoplegia in 1 studies

2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhang, M1
Hallows, JL1
Wang, X1
Bu, B1
Wang, W1
Vincent, I1

Other Studies

1 other study available for pd 98059 and Neurovisceral Storage Disease with Vertical Supranuclear Ophthalmoplegia

ArticleYear
Mitogen-activated protein kinase activity may not be necessary for the neuropathology of Niemann-Pick type C mice.
    Journal of neurochemistry, 2008, Volume: 107, Issue:3

    Topics: Animals; Blotting, Western; Brain; Disease Models, Animal; Enzyme Inhibitors; Flavonoids; Immunohist

2008